Chapter 1: Introduction
 1.1 Research Objectives
 1.2 Research Methodology
 1.3 Research Process
 1.4 Scope and Coverage
  1.4.1 Market Definition
  1.4.2 Key Questions Answered
 1.5 Market Segmentation

Chapter 2:Executive Summary

Chapter 3:Growth Opportunities By Segment
 3.1 By Type
 3.2 By Application

Chapter 4: Market Landscape
 4.1 Porter's Five Forces Analysis
  4.1.1 Bargaining Power of Supplier
  4.1.2 Threat of New Entrants
  4.1.3 Threat of Substitutes
  4.1.4 Competitive Rivalry
  4.1.5 Bargaining Power Among Buyers
 4.2 Industry Value Chain Analysis
 4.3 Market Dynamics
  4.3.1 Drivers
  4.3.2 Restraints
  4.3.3 Opportunities
  4.5.4 Challenges
 4.4 Pestle Analysis
 4.5 Technological Roadmap
 4.6 Regulatory Landscape
 4.7 SWOT Analysis
 4.8 Price Trend Analysis
 4.9 Patent Analysis
 4.10 Analysis of the Impact of Covid-19
  4.10.1 Impact on the Overall Market
  4.10.2 Impact on the Supply Chain
  4.10.3 Impact on the Key Manufacturers
  4.10.4 Impact on the Pricing

Chapter 5: NGS Tumor Gene Analysis Software Market by Type
 5.1 NGS Tumor Gene Analysis Software Market Overview Snapshot and Growth Engine
 5.2 NGS Tumor Gene Analysis Software Market Overview
 5.3 Non-Small Cell Lung Cancer
  5.3.1 Introduction and Market Overview
  5.3.2 Historic and Forecasted Market Size (2016-2030F)
  5.3.3 Key Market Trends, Growth Factors and Opportunities
  5.3.4 Non-Small Cell Lung Cancer: Geographic Segmentation
 5.4 Human 6 Gene Mutations
  5.4.1 Introduction and Market Overview
  5.4.2 Historic and Forecasted Market Size (2016-2030F)
  5.4.3 Key Market Trends, Growth Factors and Opportunities
  5.4.4 Human 6 Gene Mutations: Geographic Segmentation
 5.5 Human 12 Gene Mutations
  5.5.1 Introduction and Market Overview
  5.5.2 Historic and Forecasted Market Size (2016-2030F)
  5.5.3 Key Market Trends, Growth Factors and Opportunities
  5.5.4 Human 12 Gene Mutations: Geographic Segmentation
 5.6 Other
  5.6.1 Introduction and Market Overview
  5.6.2 Historic and Forecasted Market Size (2016-2030F)
  5.6.3 Key Market Trends, Growth Factors and Opportunities
  5.6.4 Other: Geographic Segmentation

Chapter 6: NGS Tumor Gene Analysis Software Market by Application
 6.1 NGS Tumor Gene Analysis Software Market Overview Snapshot and Growth Engine
 6.2 NGS Tumor Gene Analysis Software Market Overview
 6.3 Hospitals and Health Systems
  6.3.1 Introduction and Market Overview
  6.3.2 Historic and Forecasted Market Size (2016-2030F)
  6.3.3 Key Market Trends, Growth Factors and Opportunities
  6.3.4 Hospitals and Health Systems: Geographic Segmentation
 6.4 Research Institute
  6.4.1 Introduction and Market Overview
  6.4.2 Historic and Forecasted Market Size (2016-2030F)
  6.4.3 Key Market Trends, Growth Factors and Opportunities
  6.4.4 Research Institute: Geographic Segmentation
 6.5 Other
  6.5.1 Introduction and Market Overview
  6.5.2 Historic and Forecasted Market Size (2016-2030F)
  6.5.3 Key Market Trends, Growth Factors and Opportunities
  6.5.4 Other: Geographic Segmentation

Chapter 7: Company Profiles and Competitive Analysis
 7.1 Competitive Landscape
  7.1.1 Competitive Positioning
  7.1.2 NGS Tumor Gene Analysis Software Sales and Market Share By Players
  7.1.3 Industry BCG Matrix
  7.1.4 Heat Map Analysis
  7.1.5 NGS Tumor Gene Analysis Software Industry Concentration Ratio (CR5 and HHI)
  7.1.6 Top 5 NGS Tumor Gene Analysis Software Players Market Share
  7.1.7 Mergers and Acquisitions
  7.1.8 Business Strategies By Top Players
 7.2 ROCHE
  7.2.1 Company Overview
  7.2.2 Key Executives
  7.2.3 Company Snapshot
  7.2.4 Operating Business Segments
  7.2.5 Product Portfolio
  7.2.6 Business Performance
  7.2.7 Key Strategic Moves and Recent Developments
  7.2.8 SWOT Analysis
 7.3 ILLUMINA
 7.4 THERMO FISHER SCIENTIFIC
 7.5 BGI GROUP
 7.6 NOVOGENE
 7.7 GENESEEQ
 7.8 AMOYDX
 7.9 BURNING ROCK MEDICINE
 7.10 GTH.O
 7.11 GOLDEN HELIX
 7.12 INC
 7.13 DIATECH PHARMACOGENETICS
 7.14 VIENNALAB DIAGNOSTICS GMBH
 7.15 3D MEDICINES

Chapter 8: Global NGS Tumor Gene Analysis Software Market Analysis, Insights and Forecast, 2016-2030
 8.1 Market Overview
 8.2 Historic and Forecasted Market Size By Type
  8.2.1 Non-Small Cell Lung Cancer
  8.2.2 Human 6 Gene Mutations
  8.2.3 Human 12 Gene Mutations
  8.2.4 Other
 8.3 Historic and Forecasted Market Size By Application
  8.3.1 Hospitals and Health Systems
  8.3.2 Research Institute
  8.3.3 Other

Chapter 9: North America NGS Tumor Gene Analysis Software Market Analysis, Insights and Forecast, 2016-2030
 9.1 Key Market Trends, Growth Factors and Opportunities
 9.2 Impact of Covid-19
 9.3 Key Players
 9.4 Key Market Trends, Growth Factors and Opportunities
 9.4 Historic and Forecasted Market Size By Type
  9.4.1 Non-Small Cell Lung Cancer
  9.4.2 Human 6 Gene Mutations
  9.4.3 Human 12 Gene Mutations
  9.4.4 Other
 9.5 Historic and Forecasted Market Size By Application
  9.5.1 Hospitals and Health Systems
  9.5.2 Research Institute
  9.5.3 Other
 9.6 Historic and Forecast Market Size by Country
  9.6.1 US
  9.6.2 Canada
  9.6.3 Mexico

Chapter 10: Eastern Europe NGS Tumor Gene Analysis Software Market Analysis, Insights and Forecast, 2016-2030
 10.1 Key Market Trends, Growth Factors and Opportunities
 10.2 Impact of Covid-19
 10.3 Key Players
 10.4 Key Market Trends, Growth Factors and Opportunities
 10.4 Historic and Forecasted Market Size By Type
  10.4.1 Non-Small Cell Lung Cancer
  10.4.2 Human 6 Gene Mutations
  10.4.3 Human 12 Gene Mutations
  10.4.4 Other
 10.5 Historic and Forecasted Market Size By Application
  10.5.1 Hospitals and Health Systems
  10.5.2 Research Institute
  10.5.3 Other
 10.6 Historic and Forecast Market Size by Country
  10.6.1 Bulgaria
  10.6.2 The Czech Republic
  10.6.3 Hungary
  10.6.4 Poland
  10.6.5 Romania
  10.6.6 Rest of Eastern Europe

Chapter 11: Western Europe NGS Tumor Gene Analysis Software Market Analysis, Insights and Forecast, 2016-2030
 11.1 Key Market Trends, Growth Factors and Opportunities
 11.2 Impact of Covid-19
 11.3 Key Players
 11.4 Key Market Trends, Growth Factors and Opportunities
 11.4 Historic and Forecasted Market Size By Type
  11.4.1 Non-Small Cell Lung Cancer
  11.4.2 Human 6 Gene Mutations
  11.4.3 Human 12 Gene Mutations
  11.4.4 Other
 11.5 Historic and Forecasted Market Size By Application
  11.5.1 Hospitals and Health Systems
  11.5.2 Research Institute
  11.5.3 Other
 11.6 Historic and Forecast Market Size by Country
  11.6.1 Germany
  11.6.2 UK
  11.6.3 France
  11.6.4 Netherlands
  11.6.5 Italy
  11.6.6 Russia
  11.6.7 Spain
  11.6.8 Rest of Western Europe

Chapter 12: Asia Pacific NGS Tumor Gene Analysis Software Market Analysis, Insights and Forecast, 2016-2030
 12.1 Key Market Trends, Growth Factors and Opportunities
 12.2 Impact of Covid-19
 12.3 Key Players
 12.4 Key Market Trends, Growth Factors and Opportunities
 12.4 Historic and Forecasted Market Size By Type
  12.4.1 Non-Small Cell Lung Cancer
  12.4.2 Human 6 Gene Mutations
  12.4.3 Human 12 Gene Mutations
  12.4.4 Other
 12.5 Historic and Forecasted Market Size By Application
  12.5.1 Hospitals and Health Systems
  12.5.2 Research Institute
  12.5.3 Other
 12.6 Historic and Forecast Market Size by Country
  12.6.1 China
  12.6.2 India
  12.6.3 Japan
  12.6.4 South Korea
  12.6.5 Malaysia
  12.6.6 Thailand
  12.6.7 Vietnam
  12.6.8 The Philippines
  12.6.9 Australia
  12.6.10 New Zealand
  12.6.11 Rest of APAC

Chapter 13: Middle East & Africa NGS Tumor Gene Analysis Software Market Analysis, Insights and Forecast, 2016-2030
 13.1 Key Market Trends, Growth Factors and Opportunities
 13.2 Impact of Covid-19
 13.3 Key Players
 13.4 Key Market Trends, Growth Factors and Opportunities
 13.4 Historic and Forecasted Market Size By Type
  13.4.1 Non-Small Cell Lung Cancer
  13.4.2 Human 6 Gene Mutations
  13.4.3 Human 12 Gene Mutations
  13.4.4 Other
 13.5 Historic and Forecasted Market Size By Application
  13.5.1 Hospitals and Health Systems
  13.5.2 Research Institute
  13.5.3 Other
 13.6 Historic and Forecast Market Size by Country
  13.6.1 Turkey
  13.6.2 Bahrain
  13.6.3 Kuwait
  13.6.4 Saudi Arabia
  13.6.5 Qatar
  13.6.6 UAE
  13.6.7 Israel
  13.6.8 South Africa

Chapter 14: South America NGS Tumor Gene Analysis Software Market Analysis, Insights and Forecast, 2016-2030
 14.1 Key Market Trends, Growth Factors and Opportunities
 14.2 Impact of Covid-19
 14.3 Key Players
 14.4 Key Market Trends, Growth Factors and Opportunities
 14.4 Historic and Forecasted Market Size By Type
  14.4.1 Non-Small Cell Lung Cancer
  14.4.2 Human 6 Gene Mutations
  14.4.3 Human 12 Gene Mutations
  14.4.4 Other
 14.5 Historic and Forecasted Market Size By Application
  14.5.1 Hospitals and Health Systems
  14.5.2 Research Institute
  14.5.3 Other
 14.6 Historic and Forecast Market Size by Country
  14.6.1 Brazil
  14.6.2 Argentina
  14.6.3 Rest of SA

Chapter 15 Investment Analysis

Chapter 16 Analyst Viewpoint and Conclusion

NGS Tumor Gene Analysis Software Scope:

Report Data	NGS Tumor Gene Analysis Software Market
NGS Tumor Gene Analysis Software Market Size in 2022	USD 2517.50 million
NGS Tumor Gene Analysis Software CAGR 2023 - 2030	5.40%
NGS Tumor Gene Analysis Software Base Year	2022
NGS Tumor Gene Analysis Software Forecast Data	2023 - 2030
Segments Covered	By Type, By Application, And by Regions
Regional Scope	North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
Key Companies Profiled	Roche, Illumina, Thermo Fisher Scientific, BGI Group, Novogene, Geneseeq, AmoyDx, Burning Rock Medicine, GTH.O, Golden Helix, Inc, Diatech Pharmacogenetics, ViennaLab Diagnostics GmbH, 3D Medicines.
Key Segments	By Type Non-Small Cell Lung Cancer Human 6 Gene Mutations Human 12 Gene Mutations Other By Applications Hospitals and Health Systems Research Institute Other